SCHEMBL19082317

SCHEMBL19082317

c1cc(-c2c3ccccc3c(-c3ccc4ccccc4c3)c3ccccc23)cc(-c2c3sc4ccccc4c3cc3c2sc2cc4ccccc4cc23)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNKS O95271 1/20 0.36
TNKS2 Q9H2K2 1/20 0.36
ALOX5 P09917 1/20 0.36
MAPT P10636 3/20 0.36
HSD17B1 P14061 1/20 0.35
HSD17B2 P37059 1/20 0.35
S1PR5 Q9H228 7/20 0.34
S1PR4 O95977 6/20 0.34
ATM Q13315 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
ESR1 P03372 2/20 0.33
ESR2 Q92731 2/20 0.33
GPR3 P46089 1/20 0.33
CYP1A1 P04798 1/20 0.32
CYP1B1 Q16678 1/20 0.32
ALDH1A1 P00352 2/20 0.32
HPGD P15428 2/20 0.32
RAB9A P51151 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
PTPN1 P18031 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17944636 0.95 ALOX5 (0.40) TNKSTNKS2ALOX5MAPTHSD17B1
SCHEMBL17945685 0.90 HSD17B1 (0.40) TNKSTNKS2ALOX5MAPTHSD17B1
SCHEMBL17944861 0.90 ALOX5 (0.38) TNKSTNKS2ALOX5MAPTHSD17B1
SCHEMBL17944218 0.89 MAPT (0.41) TNKSTNKS2ALOX5MAPTHSD17B1
SCHEMBL19077364 0.89 ALOX5 (0.39) TNKSTNKS2ALOX5MAPTHSD17B1
SCHEMBL19082205 0.89 TNKS (0.39) TNKSTNKS2ALOX5MAPTHSD17B1
SCHEMBL19077379 0.88 HSD17B1 (0.39) ALOX5MAPTHSD17B1HSD17B2S1PR5
SCHEMBL17944272 0.87 HSD17B1 (0.38) TNKSTNKS2ALOX5MAPTHSD17B1
SCHEMBL19077380 0.87 HSD17B1 (0.40) ALOX5MAPTHSD17B1HSD17B2S1PR5
SCHEMBL17944232 0.86 TNKS (0.44) TNKSTNKS2ALOX5MAPTHSD17B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 TNKS 2635/4885TNKS2 2644/4885ALOX5 1939/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 TNKS 2635/4885TNKS2 2644/4885ALOX5 1939/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.